Malignancy in patients with sarcoidosis

dc.authoridKOBAK, SENOL/0000-0001-8270-640X
dc.authorscopusid12782228700
dc.authorscopusid57195398766
dc.authorscopusid57006709600
dc.authorscopusid6701401491
dc.authorwosidKOBAK, SENOL/AAO-2482-2020
dc.authorwosidorman, mehmet/JUU-4618-2023
dc.contributor.authorKobak, Senol
dc.contributor.authorYildiz, Fidan
dc.contributor.authorSemiz, Huseyin
dc.contributor.authorOrman, Mehmet
dc.date.accessioned2024-05-25T11:42:17Z
dc.date.available2024-05-25T11:42:17Z
dc.date.issued2021
dc.departmentOkan Universityen_US
dc.department-temp[Kobak, Senol] Istinye Univ, LIV Hosp, Fac Med, Dept Rheumatol, Istanbul, Turkey; [Yildiz, Fidan] Okan Univ, Fac Med, Dept Chest Dis, Istanbul, Turkey; [Semiz, Huseyin] Ege Univ, Fac Med, Dept Internal Med, Bornova, Turkey; [Orman, Mehmet] Ege Univ, Fac Med, Dept Stat, Bornova, Turkeyen_US
dc.descriptionKOBAK, SENOL/0000-0001-8270-640X;en_US
dc.description.abstractThe relationship between sarcoidosis and malignancy is not clear yet. We retrospectively evaluated 131 sarcoidosis patients followed-up at the single Rheumatology center. The incidence of malignancies was investigated in this cohort. A total of 6 (4.6%) patients with malignancy were identified in our cohort of 131 patients with sarcoidosis. Hodgkin lymphoma (HL) was detected in three patients, followed by one patient with breast cancer, one patient with thyroid cancer and one patient with testicular cancer. All patients had chronic sarcoidosis with pulmonary involvement, and only 1 patient had acute sarcoidosis with Lofgren's syndrome. HL developed concomitantly with sarcoidosis in one patient while other two patients developed disease before and after sarcoidosis diagnosis. Two patients with solid tumors developed malignancy years before sarcoidosis diagnosis, while one patient developed thyroid cancer during sarcoidosis follow-up. All 6 sarcoidosis-malignancy patients survived after six year years follow up. We found low incidence of malignancy in patients with sarcoidosis in our small cohort. The sarcoidosis-malignancy relationship can only be a coincidence and/or can be explained by a common pathogenesis. New prospective studies involving large patients series are needed in this regard. (C) 2019 Elsevier Espafia, S.L.U. and Sociedad Espafiola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.en_US
dc.identifier.citation7
dc.identifier.doi10.1016/j.reuma.2019.04.003
dc.identifier.endpage51en_US
dc.identifier.issn1699-258X
dc.identifier.issn1885-1398
dc.identifier.issue1en_US
dc.identifier.pmid31153889
dc.identifier.scopus2-s2.0-85066129328
dc.identifier.scopusqualityQ3
dc.identifier.startpage49en_US
dc.identifier.urihttps://doi.org/10.1016/j.reuma.2019.04.003
dc.identifier.urihttps://hdl.handle.net/20.500.14517/1572
dc.identifier.volume17en_US
dc.identifier.wosWOS:000608393600010
dc.language.isoen
dc.publisherElsevier Espana Sluen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSarcoidosisen_US
dc.subjectMalignidaden_US
dc.subjectIncidenciaen_US
dc.titleMalignancy in patients with sarcoidosisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files